Results 271 to 280 of about 234,996 (348)

Proteomic Identification of IL4I1 as a Therapeutic Target in P53-Mutant Endometrial Cancer. [PDF]

Cancers (Basel)
Li H, Zhang R, Sui T, Wang K, Li Y, Luo X, He Q.   +6 more
europepmc   +1 more source

Women's and Health Care Professionals' Experiences of Discontinuing Hormone Replacement Therapy (HRT): A Systematic Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Hormone Replacement Therapy (HRT) is used to manage menopausal symptoms, particularly vasomotor symptoms (VMS). HRT prescribing rates are rising, but most women will eventually discontinue. Objectives To explore the experiences of women stopping HRT, why women restart HRT, and the HCPs advising them. Search Strategy Embase, MEDLINE,
Sarah Bunnewell, Sabrina Keating, Jo Parsons, Martha Hickey, Sarah Hillman   +4 more
wiley   +1 more source

Comprehensive bioinformatics evaluation uncovers the possible oncogenic contribution of acrylamide to endometrial cancer. [PDF]

Discov Oncol
Zou Y, Lu S, Han S, Zhao R.
europepmc   +1 more source

Cell‐Free and Concentrated Ascites Reinfusion Therapy (CART) Shows Enhanced Efficacy in Gynecological Cancer Patients: A Post‐Marketing Surveillance Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Ascites management is crucial for gynecological cancer patients requiring long‐term treatment. Cancer type‐specific differences may influence CART outcomes, but comparative data remain limited. This study evaluated CART efficacy in gynecological versus other cancers.
Nami Tamura, Takashi Hirayama, Emiko Yoshida, Junna Terao, Misato Kawata, Kengo Hiranuma, Toshiyuki Okumura, Kazunari Fujino, Naoko Torii, Noriko Soneda, Go Murayama, Makio Kusaoi, Ken Yamaji, Yasuhisa Terao   +13 more
wiley   +1 more source

Carbohydrate Antigen-125: Endometrial Cancer or Heart Failure Biomarker? [PDF]

JACC Case Rep
Rao VU, Fretz T, Ayeni T, Skurka K, Raghavendra M, Kalra A.   +5 more
europepmc   +1 more source

Development and Real‐World Evaluation of a Statewide Mainstream Model of Germline Genetic Testing for BRCA1/2 and Mismatch Repair Gene Variants (Lynch Syndrome)

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This translational quality improvement study evaluated a statewide pathway for mainstream genetic testing in South Australia. Adoption of mainstream BRCA1/2 testing increased significantly, but not MMR testing. Findings highlight the need for tailored, context‐specific strategies to integrate genetic testing into routine care across diverse cancer ...
Cally A. Jennings, Kathryn Cornthwaite, Michael Osborn, Ganessan Kichenadasse, Eryn Dow   +4 more
wiley   +1 more source

Quality of Life Among Thai Patients With Advanced Cancer: Findings From the APPROACH Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Cancer is the leading cause of death in Thailand, but quality of life with cancer is not well understood. Thai patients had relatively high quality of life, but the pervasiveness of self‐blame and its association with reduced quality of life, and the large proportion with depressive symptoms, stresses the need for mental health care.
Waranee Bunchuailua, Nattiya Kapol, Sineenart Krichanchai, Waranya Krongkaew, Ellie Bostwick Andres   +4 more
wiley   +1 more source

Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer. [PDF]

NPJ Precis Oncol
Vargas R, Petty A, Lindner DJ, Parker Y, Yard B, Durmaz A, Lin-Rahardja K, Reizes O, Debernardo R, Scott J.   +9 more
europepmc   +1 more source